Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review
Goey, Kaitlyn K.H, t Lam-Boer, Jorine, de Wilt, Johannes H.W, Punt, Cornelis J.A, van Oijen, Martijn G.H, Koopman, Miriam
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer
Ten Hoorn, Sanne, Waasdorp, Cynthia, van Oijen, Martijn G H, Damhofer, Helene, Trinh, Anne, Zhao, Lan, Smits, Lisanne J H, Bootsma, Sanne, van Pelt, Gabi W, Mesker, Wilma E, Mol, Linda, Goey, Kaitlyn K H, Koopman, Miriam, Medema, Jan Paul, Tuynman, Jurriaan B, Zlobec, Inti, Punt, Cornelis J A, Vermeulen, Louis, Bijlsma, Maarten F
Published in BMC cancer (12.04.2022)
Published in BMC cancer (12.04.2022)
Get full text
Journal Article
Prognostic value of primary tumor resection in synchronous metastatic colorectal cancer (mCRC): Individual patient data (IPD) analysis of first-line randomized trials from the ARCAD database
Koopman, Miriam, Shi, Qian, Goey, Kaitlyn K.H., Green, Erin, Heinemann, Volker, Diaz-Rubio, Eduardo, Aranda, Enrique, Falcone, Alfredo, De Gramont, Aimery, Sargent, Daniel J., Punt, Cornelis J. A.
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review
Goey, Kaitlyn K.H., Mahmoud, Remi, Sørbye, Halfdan, Glimelius, Bengt, Köhne, Claus-Henning, Sargent, Daniel J., Punt, Cornelis J.A., van Oijen, Martijn G.H., Koopman, Miriam
Published in European journal of cancer (1990) (01.06.2018)
Published in European journal of cancer (1990) (01.06.2018)
Get full text
Journal Article
Predictive value of KRAS mutation status in metastatic colorectal cancer (mCRC) patients treated with capecitabine and bevacizumab (CAP-B) maintenance treatment vs observation in the phase III CAIRO3 study
Goey, Kaitlyn K.H., Elias, Sjoerd G., van Tinteren, Harm, Lacle, Miangela M., Willems, Stefan M., de Leng, Wendy W.J., Strengman, Eric, Vreuls, Celien, Creemers, Geert-Jan, Van Der Velden, Ankie, Punt, Cornelis J. A., Koopman, Miriam
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article